A detailed history of State Of Tennessee, Treasury Department transactions in Moderna, Inc. stock. As of the latest transaction made, State Of Tennessee, Treasury Department holds 123,416 shares of MRNA stock, worth $4.55 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
123,416
Previous 106,403 15.99%
Holding current value
$4.55 Million
Previous $12.6 Million 34.73%
% of portfolio
0.03%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $1.08 Million - $2.13 Million
17,013 Added 15.99%
123,416 $8.25 Million
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $122,868 - $202,264
-1,214 Reduced 1.13%
106,403 $12.6 Million
Q1 2024

May 14, 2024

SELL
$85.37 - $115.44 $4.02 Million - $5.44 Million
-47,147 Reduced 30.46%
107,617 $11.5 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $4.71 Million - $7.08 Million
67,786 Added 77.93%
154,764 $15.4 Million
Q2 2023

Aug 15, 2023

BUY
$118.5 - $160.53 $4.18 Million - $5.66 Million
35,264 Added 68.19%
86,978 $10.6 Million
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $16.2 Million - $23.6 Million
-119,713 Reduced 69.83%
51,714 $7.94 Million
Q4 2022

Feb 15, 2023

BUY
$118.38 - $210.04 $9.43 Million - $16.7 Million
79,657 Added 86.8%
171,427 $30.8 Million
Q3 2022

Jan 26, 2023

SELL
$118.07 - $194.18 $102,130 - $167,965
-865 Reduced 0.93%
91,770 $10.9 Million
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $4.22 Million - $6.36 Million
36,030 Added 63.65%
92,635 $13.2 Million
Q1 2022

May 11, 2022

SELL
$126.46 - $235.05 $9.51 Million - $17.7 Million
-75,219 Reduced 57.06%
56,605 $9.75 Million
Q4 2021

Feb 15, 2022

SELL
$225.82 - $368.51 $2.36 Million - $3.86 Million
-10,463 Reduced 7.35%
131,824 $33.5 Million
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $31.6 Million - $68.9 Million
142,287 New
142,287 $54.8 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track State Of Tennessee, Treasury Department Portfolio

Follow State Of Tennessee, Treasury Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.